FDA Adverse Event Malfunction Summary report: N

COLOGUARD

MDR report key: 19751215 · Received July 15, 2024

Report

Report Number
MW5157297
Event Type
Malfunction
Date Received
July 15, 2024
Date of Event
February 22, 2024
Report Date
July 11, 2024
Manufacturer
EXACT SCIENCES CORPORATION
Product Code
PHP
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NJ, US
Reporter Occupation
PATIENT
Health Professional
*

Narratives

Description of Event or Problem · 0

I AM REPORTING THIS ONLY AS I BELIEVE THE KIT HAS MORE FALSE POSITIVES OR THERE ARE ISSUES WITH INADEQUATE TESTING BEING PERFORMED ON THE KIT SAMPLES. I AM 64 YEAR AND MY DOCTOR ORDERED THE COLOGUARD TEST FOR ME. I COLLECTED THE SAMPLE AND SHIPPED AS INSTRUCTED. THE TEST CAME BACK POSITIVE FOR FECAL OCCULT BLOOD, POSITIVE FIT-DNA TEST AND ABNORMAL FECES. I SCHEDULED AND RECEIVED A COLONOSCOPY. WHERE THE FECAL BLOOD FINDING WAS POSSIBLE DUE TO FINDING HEMORRHOIDS AND MILD DIVERTICULOSIS, THE FIT-DNA TEST WAS OBVIOUSLY WRONG AS THE COLONOSCOPY FOUND NO EVIDENCE OF POLYPS OR PRE-CANCEROUS LESIONS AND NORMAL MUCOSA. MY GI DOCTOR INDICATED MY NEXT COLONOSCOPY TO BE SCHEDULED IN 10 YEARS. TO HAVE THE FITDNA TEST POSITIVE WITH NOTHING TO CAUSE A FALSE POSITIVE TO ME INDICATES ONE OF 3 THINGS. THE FIT TEST IS UNRELIABLE, THE METHODS TO RUN THE FIT-DNA TEST BY COLOGUARD ARE SUBSTANDARD OR THE TECHNICIAN, WHO RAN THE TEST, WAS INADEQUATELY TRAINED OR DECIDED THEY DIDN'T WANT TO INTENTIONALLY MISHANDLE THE SAMPLE DUE TO ITS CONDITION. I AM REPORTING THIS SOLELY AS A POSSIBLE AREA OF FOCUS DURING THE NEXT INSPECTION. THE REPORT INDICATED THAT COLORGUARD RECOMMENDS REPEATING THE TEST EVERY 3 YEARS, WHILE MY GI DOCTOR INDICATED THE NEXT COLONOSCOPY IN 10 YEARS. IS THERE PERHAPS A FINANCIAL MOTIVE BEHIND THESE TESTS? RESULTING LABS (B)(6).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
748104 COLOGUARD SYSTEM, COLORECTAL NEOPLASIA, DNA METHYLATION AND HEMOGLOBIN DETECTION PHP EXACT SCIENCES CORPORATION

Patients

Seq Age Sex Outcome Treatment
1 Female Other